A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
major objective This multicenter, prospective cohort study aims at evaluating the predictive value of microbiome ,proteomics and serum markers in preeclampsia. secondary objective to evaluate the value of microbiome,proteomics and serum markers in assessing pregnancy outcome (complications during pregnancy and delivery, delivery) and neonatal prognosis.
Conditions studied
Preeclampsia, Microbiome
About this study
major objective This multicenter, prospective cohort study aims at evaluating the predictive value of microbiome ,proteomics and serum markers in preeclampsia. secondary objective to evaluate the value of microbiome,proteomics and serum markers in assessing pregnancy outcome (complications during pregnancy and delivery, delivery) and neonatal prognosis.
Interventions
- Other: Observational studies, The diagnosis was preeclampsia — Observational studies, The diagnosis was preeclampsia
Primary outcomes
- microbiome (34 months)
- proteomics (34 months)
- metabonomics (34 months)
Eligibility information
Study locations
- Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510000 China
- Zhujiang hospital, Guangzhou, Guangdong 510000 China
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.